2399 — Biostar Microtech International Income Statement
0.000.00%
Last trade - 00:00- TWD6.63bn
- TWD5.08bn
- TWD1.73bn
Annual income statement for Biostar Microtech International, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,775 | 2,236 | 2,344 | 2,019 | 1,734 |
| Cost of Revenue | |||||
| Gross Profit | 520 | 269 | 135 | 166 | 112 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 2,558 | 2,235 | 2,474 | 2,126 | 1,886 |
| Operating Profit | 217 | 1.53 | -130 | -107 | -152 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 407 | 16.2 | -117 | 28.2 | 27.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 362 | 12.9 | -113 | 6.62 | 26.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 362 | 12.9 | -113 | 6.62 | 26.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 362 | 12.9 | -113 | 6.62 | 26.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.01 | 0.072 | -0.636 | 0.037 | 0.147 |
| Dividends per Share |